Centru De Evaluare Si Tratament A Toxicodependentelor Pentru Tineri Sf. Stelian

The Centru De Evaluare Si Tratament A Toxicodependentelor Pentru Tineri Sf. Stelian conducts research that examines how targeted behavioral strategies can improve outcomes for patients with serious psychiatric conditions such as schizophrenia, bipolar I disorder, and major depressive disorder.

• Adjunctive treatments for schizophrenia
• Management of mania and mixed features in bipolar disorder
• Strategies to reduce agitation in Alzheimer’s dementia
• Relapse prevention for depression with anhedonia
• Long‑term safety assessments of novel psychotropic agents

With 13 active studies and a team of seven investigators, the site offers a comprehensive platform for evaluating new therapies and behavioral interventions in a real‑world clinical setting.

Research at this Bucharest hospital focuses on the core mental disorders that affect young adults, including schizophrenia, bipolar I disorder, and major depressive disorder. The goal is to test innovative drugs and combination regimens that may provide faster relief and better long‑term stability.

• Efficacy of new antipsychotics for treatment‑resistant schizophrenia
• Acute and maintenance therapy for bipolar mania
• Adjunctive antidepressant strategies for moderate‑to‑severe anhedonia
• Treatment of psychosis associated with Alzheimer’s disease
• Safety monitoring of long‑term adjunctive therapies

The program integrates clinical expertise with rigorous trial design, aiming to expand therapeutic options for patients struggling with severe mental illness.

Studies under the Psychological Phenomena umbrella explore specific symptom clusters such as anhedonia and agitation, seeking to understand how these experiences impact overall disease burden and treatment response.

• Assessing relapse risk linked to anhedonia in depression
• Measuring agitation levels in Alzheimer’s dementia
• Evaluating behavioral and psychological symptoms of schizophrenia
• Investigating mood stabilization in bipolar patients with mixed features
• Long‑term tolerability of novel agents addressing psychological symptoms

By linking symptom‑focused outcomes with broader clinical endpoints, the site contributes valuable insights that may guide personalized treatment strategies.